Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Pinotti

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Pharmaceutics|April 20, 2012
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectorsRita Cortesi, Paola Bergamini, Laura Ravani, et al.
Human Molecular Genetics|February 25, 2012
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defectsEugenio Fernandez Alanis, Mirko Pinotti, Andrea Dal Mas, et al.
The Biochemical Journal|October 3, 2002
Factor VII mutant V154G models a zymogen-like form of factor VIIaRaffaella Toso, Francesco Bernardi, Theresa Tidd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 23, 2007
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticlesMarcello Baroni, Cinzia Pizzirani, Mirko Pinotti, et al.
American Journal of Human Genetics|July 9, 2021
Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein functionSilvia Lombardi, Gabriele Leo, Simone Merlin, et al.
Molecular Therapy. Nucleic Acids|November 30, 2016
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based TherapeuticsElena Barbon, Mattia Ferrarese, Laetitia van Wittenberghe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal conditionMattia Ferrarese, Marcello Baroni, Patrizia Della Valle, et al.
Haematologica|August 4, 2022
Translational readthrough at <i>F8</i> nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor associationMaria Francesca Testa, Silvia Lombardi, Francesco Bernardi, et al.
Molecular and Cellular Biology|March 5, 2008
Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillatorsCristiano Bertolucci, Nicola Cavallari, Ilaria Colognesi, et al.
Thrombosis Research|April 1, 2020
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart diseaseMarcello Baroni, Nicola Martinelli, Barbara Lunghi, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Pharmaceutics|April 20, 2012
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectorsRita Cortesi, Paola Bergamini, Laura Ravani, et al.
Human Molecular Genetics|February 25, 2012
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defectsEugenio Fernandez Alanis, Mirko Pinotti, Andrea Dal Mas, et al.
The Biochemical Journal|October 3, 2002
Factor VII mutant V154G models a zymogen-like form of factor VIIaRaffaella Toso, Francesco Bernardi, Theresa Tidd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 23, 2007
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticlesMarcello Baroni, Cinzia Pizzirani, Mirko Pinotti, et al.
American Journal of Human Genetics|July 9, 2021
Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein functionSilvia Lombardi, Gabriele Leo, Simone Merlin, et al.
Molecular Therapy. Nucleic Acids|November 30, 2016
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based TherapeuticsElena Barbon, Mattia Ferrarese, Laetitia van Wittenberghe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 18, 2019
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal conditionMattia Ferrarese, Marcello Baroni, Patrizia Della Valle, et al.
Haematologica|August 4, 2022
Translational readthrough at <i>F8</i> nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor associationMaria Francesca Testa, Silvia Lombardi, Francesco Bernardi, et al.
Molecular and Cellular Biology|March 5, 2008
Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillatorsCristiano Bertolucci, Nicola Cavallari, Ilaria Colognesi, et al.
Thrombosis Research|April 1, 2020
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart diseaseMarcello Baroni, Nicola Martinelli, Barbara Lunghi, et al.
Pageof 10